Related content

Expression and Distribution of S-100, CD83, and Costimulatory Molecules (CD80 and CD86) in Tissues of Thyroid Papillary Carcinoma

By Xu Wen-Can   Li Zheng-Bing   Chen Yong-Ru   Li Xi-Tao   Huang Jie-Xiong   Li Yu-Guang   Chen Shen-Ren  

Cancer Investigation, Vol. 29, Iss. 4, 2011-04 ,pp. : 286-292

Informa Healthcare

Access to resources Recommend Favorite

Down-regulation of HLA class II and costimulatory CD86/B7-2 on circulating monocytes from melanoma patients

By Ugurel Selma   Uhlig Dario   Pföhler Claudia   Tilgen Wolfgang   Schadendorf Dirk   Reinhold Uwe  

Cancer Immunology, Immunotherapy, Vol. 53, Iss. 6, 2004-06 ,pp. : 551-559

Springer Publishing Company

Access to resources Recommend Favorite

Vasoactive intestinal peptide induces CD14+HLA-DR/low myeloid-derived suppressor cells in gastric cancer

By                        

Molecular Medicine Reports, Vol. 12, Iss. 1, 2015-01 ,pp. : 760-768

Spandidos Publications

Access to resources Recommend Favorite

CD80 (B7.1) and CD86 (B7.2) induce EBV-transformed B cell apoptosis through the Fas/FasL pathway

By            

International Journal of Oncology, Vol. 43, Iss. 5, 2013-01 ,pp. : 1531-1540

Spandidos Publications

Access to resources Recommend Favorite

Development of Immunogenic Colorectal Cancer Cell Lines for Vaccination: Expression of CD80 (B7.1) is not Sufficient to Restore Impaired Primary T Cell Activation In Vitro

By Habicht A.   Lindauer M.   Galmbacher P.   Rudy W.   Gebert J.   Schackert H.-K.   Meuer S.C.   Moebius U.  

European Journal of Cancer, Vol. 31, Iss. 13, 1995-12 ,pp. : 2396-2402

Elsevier

Access to resources Recommend Favorite